Cardinal Capital Management Inc (North Carolina)’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-31,208
| Closed | -$549K | – | 133 |
|
|
2019
Q1 | $549K | Buy |
31,208
+1,136
| +4% | +$20K | 0.16% | 116 |
|
|
2018
Q4 | $522K | Buy |
30,072
+1,160
| +4% | +$20.1K | 0.17% | 112 |
|
|
2018
Q3 | $430K | Sell |
28,912
-40
| -0.1% | -$595 | 0.12% | 123 |
|
|
2018
Q2 | $460K | Buy |
28,952
+543
| +2% | +$8.63K | 0.14% | 121 |
|
|
2018
Q1 | $403K | Buy |
28,409
+85
| +0.3% | +$1.21K | 0.13% | 113 |
|
|
2017
Q4 | $397K | Sell |
28,324
-1,335
| -5% | -$18.7K | 0.12% | 114 |
|
|
2017
Q3 | $424K | Sell |
29,659
-26,258
| -47% | -$375K | 0.13% | 115 |
|
|
2017
Q2 | $881K | Buy |
55,917
+10,108
| +22% | +$159K | 0.29% | 89 |
|
|
2017
Q1 | $632K | Buy |
45,809
+5,846
| +15% | +$80.7K | 0.23% | 94 |
|
|
2016
Q4 | $707K | Buy |
39,963
+2,074
| +5% | +$36.7K | 0.27% | 90 |
|
|
2016
Q3 | $731K | Buy |
37,889
+3,671
| +11% | +$70.8K | 0.29% | 82 |
|
|
2016
Q2 | $667K | Buy |
34,218
+2,081
| +6% | +$40.6K | 0.27% | 84 |
|
|
2016
Q1 | $662K | Buy |
32,137
+2,512
| +8% | +$51.7K | 0.28% | 79 |
|
|
2015
Q4 | $608K | Buy |
29,625
+1,268
| +4% | +$26K | 0.27% | 81 |
|
|
2015
Q3 | $485K | Buy |
28,357
+4,056
| +17% | +$69.4K | 0.23% | 90 |
|
|
2015
Q2 | $453K | Buy |
24,301
+5,444
| +29% | +$101K | 0.2% | 91 |
|
|
2015
Q1 | $360K | Buy |
18,857
+4,416
| +31% | +$84.3K | 0.15% | 96 |
|
|
2014
Q4 | $238K | Buy |
14,441
+877
| +6% | +$14.5K | 0.11% | 103 |
|
|
2014
Q3 | $240K | Buy |
+13,564
| New | +$240K | 0.11% | 98 |
|